Despite the increasing burden of prostate cancer and the availability of low cost services such as the use of human papillomavirus (HPV) and PSA [12] screening tools, testing for the purpose of early detection of cases remains low in most poor resource settings. The gene discussed is KLK3; the disease is prostate carcinoma.